NEW YORK (GenomeWeb) –The Centers for Medicare & Medicaid Services released a final rule this week for public comment revising its controversial 14-day rule that has long hindered molecular diagnostics labs from directly billing the government payor when tests are ordered within two weeks of an outpatient's discharge from the hospital.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.